Strasbourg, France, August 31, 2022, 05:45 p.m. CEST – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that Management will participate in the upcoming investor events set out below:
 
 
 -	Pareto Securities, 13th Annual Healthcare Conference – Stockholm, Sweden
 
 September 8, 2022
 
 
 -	Transgene’s R&D Day – Paris, France
 
 September 27, 2022
 
 
 -	Investor Access Forum – Paris, France
 
 October 6 & 7, 2022
 
 
 -	HealthTech Innovation Days 2022 – Paris, France
 
 October 13 & 14, 2022
 
 
 -	EigenKapitalForum – Frankfurt (Main), Germany
 
 November 28, 2022
 
 
 .../...
                                            
                                            
                                        
                                            
                                            
                                        
                                            
                                            
                                        
                                            
                                            
                                        
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer